Multiple studies show COVID vaccines dont protect kids
One study (
https://bit.ly/3iru5qJ) done in New York state found that
the Pfizer COVID-19 vaccine was only 12 percent effective against
the B11529 omicron variant. The Feb. 28 pre-print study published
in medRxiv examined data from two groups of children in the Empire
State from Dec. 13, 2021 to Jan. 30.
In the group of children aged five to 11 years old, vaccine
effectiveness against omicron dropped from 68 percent to 12 percent
during the period. The study also pointed out that the vaccines
ability to protect against COVID-19 hospitalizations in children
aged five to 11 dropped from 100 percent in December to 48 percent
in January.
A similar observation was found among vaccinated children 12 to 17
years old. From 66 percent in December, vaccine effectiveness against
omicron infections fell to 51 percent in January. Protection against
hospitalization in the same cohort dropped from 85 percent to 73
percent, the study added.
There is limited evidence on the effectiveness of the [Pfizer]
BNT162b2 vaccine for children, particularly those [aged five to 11],
and after the omicron variants emergence. In the omicron era, the
[Pfizer shots] effectiveness against [omicron] cases declined
rapidly, wrote the authors of the New York study. Incidentally, the
U.S. Food and Drug Administration (FDA)approved the Pfizer
vaccine for use in children aged between five and 17 years old.
Another study (
https://bit.ly/3ihrzUa), this time in England, proved
the Pfizer COVID-19 vaccine offers little to no protection against
the omicron strain. According to the March 2 paper published in
the New England Journal of Medicine, two doses of the shot only
imbued a measly 8.8 percent protection against omicron 25 weeks
after vaccination and beyond. A similar result was observed in the
Moderna mRNA-1273 vaccine, with two doses only offering 14.9
percent protection against omicron 25 weeks after injection and
beyond.
Dr. H. Cody Meissner, a member of the FDAs Vaccines and Related
Biological Products Advisory Committee, put in his two cents on the
matter. He said the studies results taken together suggest that the
benefit roughly equals the risk of harm for many children injected
with the shots. Its not even clear that this vaccine will reduce
rates of transmission. This vaccine is probably not going to prevent
infection, Meissner told the Epoch Times (
https://bit.ly/3L3C21X).
According to the FDA committee member, diminished protection means
that its benefits are almost the same as the risks that come with it.
These risks include cases of myocarditis and pericarditis observed
in some children injected with the Pfizer shot. Myocarditis involves
the inflammation of the heart muscle, while pericarditis involves
the inflammation of the lining or sac surrounding the heart.
It really should be up to the parents to decide whether they want to
immunize their child. I think they need to be informed [and they]
need to educate themselves. [The Pfizer COVID-19 vaccine] may
reduce the risk of death, but the risk of death is so small [that]
its almost negligible, added Meisner.
Florida Surgeon General Dr. Joseph Ladapo went the extra mile
on the issue of vaccines for children, releasing guidance that
advised against injecting children with the shots. His offices March
8 guidance (
https://bit.ly/3ubithl) stated that based on currently
available data, healthy children aged five to 17 may not benefit from
receiving the currently available COVID-19 vaccines.
In general, healthy children with no significant, underlying
conditions under 16 years old are at little to no risk of severe
illness complications from COVID-19. For adolescents 16 to 17 years
old, the risk of myocarditis due to the COVID-19 vaccines may
outweigh the benefits.
